Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP3121850B2 - Method for isolating acid secretion inhibitor - Google Patents
[go: Go Back, main page]

JP3121850B2 - Method for isolating acid secretion inhibitor - Google Patents

Method for isolating acid secretion inhibitor

Info

Publication number
JP3121850B2
JP3121850B2 JP03034225A JP3422591A JP3121850B2 JP 3121850 B2 JP3121850 B2 JP 3121850B2 JP 03034225 A JP03034225 A JP 03034225A JP 3422591 A JP3422591 A JP 3422591A JP 3121850 B2 JP3121850 B2 JP 3121850B2
Authority
JP
Japan
Prior art keywords
panax
ginseng
carrot
acid secretion
cameyer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP03034225A
Other languages
Japanese (ja)
Other versions
JPH04273824A (en
Inventor
裕 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Priority to JP03034225A priority Critical patent/JP3121850B2/en
Publication of JPH04273824A publication Critical patent/JPH04273824A/en
Application granted granted Critical
Publication of JP3121850B2 publication Critical patent/JP3121850B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、薬用ニンジンまたはそ
の組織培養物から単離される新規な酸分泌抑制物質、お
よびその単離方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel acid secretion inhibitor isolated from a medicinal carrot or a tissue culture thereof, and a method for isolating the same.

【0002】[0002]

【従来の技術】薬用ニンジン、例えば、オタネニンジン
Panax ginseng C.A.Meyer)は、抗疲労作用、抗スト
レス作用、新陳代謝亢進作用などの薬効を有することが
知られている。さらに、胃腸機能の改善にも有用であ
る。このような胃腸機能の改善は、薬用ニンジンの酸分
泌抑制作用によるものと考えられる。薬用ニンジンの酸
分泌抑制作用の活性成分としては、これまでに、サポニ
ンの1種であるジンセノサイドが報告されているが、そ
の他の成分に関しては解明されていない。酸分泌作用を
有するニンジン由来のその他の物質を得ることができれ
ば、これを用いた新たな薬剤を提供することも可能にな
ると考えられる。
2. Description of the Related Art Medicinal carrots, for example, Panax ginseng CAMeyer, are known to have a pharmacological effect such as an anti-fatigue effect, an anti-stress effect, and a metabolic hyperactivity. It is also useful for improving gastrointestinal function. It is considered that such improvement in gastrointestinal function is due to the action of medicinal carrots to suppress acid secretion. Ginsenoside, a kind of saponin, has been reported as an active ingredient for inhibiting the secretion of acid by medicinal carrots, but other components have not been elucidated. If other carrot-derived substances having an acid secretion action could be obtained, it would be possible to provide new drugs using the same.

【0003】[0003]

【発明が解決しようとする課題】本発明は、上記従来の
問題点を解決するものであり、その目的とするところ
は、薬用ニンジンに含有されるサポニン以外の酸分泌抑
制物質を提供すること、およびその酸分泌抑制物質を単
離する方法を提供することにある。
DISCLOSURE OF THE INVENTION The object of the present invention is to solve the above-mentioned conventional problems, and an object of the present invention is to provide an acid secretion inhibitor other than saponin contained in a medicinal carrot, And a method for isolating the acid secretion inhibitor.

【0004】[0004]

【課題を解決するための手段】本発明の酸分泌抑制物質
の単離方法は、薬用ニンジンまたはその組織培養物、ま
たはそれらの乾燥物を水性有機溶媒で抽出する工程;得
られた抽出物を有機溶媒で沈澱させ、沈澱物を採取する
工程;および該沈澱物を限外濾過処理に供し、分子量14
000以下の低分子画分を採取する工程を包含し、そのこ
とにより上記目的が達成される。
The method for isolating an acid secretion inhibitor according to the present invention comprises a step of extracting a medicinal carrot or a tissue culture thereof or a dried product thereof with an aqueous organic solvent; Precipitating with an organic solvent and collecting the precipitate; and subjecting the precipitate to ultrafiltration to give a molecular weight of 14
Collecting the low molecular fraction of 000 or less, thereby achieving the above object.

【0005】本発明に用いられる薬用ニンジンとして
は、オタネニンジン(Panax ginsengC.A.Meyer)、トチ
バニンジン(Panax japonicus C.A.Meyer)、アメリカ
ニンジン(Panax quinquefolium L.)、三七ニンジン
Panax notoginseng (Burk.)F.H.Chen)、ヒマラヤニ
ンジン(Panax pseudo-ginsengWall. subsp. himalaicu
sHara)、珠子参(Panax japonics C.A.Meyer var. maj
or(Burk.) C.Y.Wu et K.M.Feng)、姜状三七(Panax zi
ngiberenesis C.Y.Wu et K.M.Feng)、屏辺三七(Panax
stipuleanatus Tsai et Feng)、狭葉竹節参(Panax j
aponics C.A.Meyer var. angustifolitus (Burk.) Chen
g et Chu)などが挙げられる。これらの薬用ニンジンの
根部またはその乾燥物が用いられる。このような乾燥物
は、例えば、白参、紅参などの漢方薬として入手でき
る。あるいは、薬用ニンジンの組織培養物を用いること
もできる。組織培養物は、通常の方法により調製され得
る。例えば、上記の薬用ニンジンの組織の一部を植物ホ
ルモンを含む固体培地で無菌的に培養してカルスを発生
させる。培養条件は、何ら格別である必要はない。培地
としては、植物の組織培養に通常用いられるムラシゲ−
スクーグの培地、ホワイトの倍地、リンスマイヤー−ス
クーグの培地、ガウスレットの培地、ヘラーの培地、ガ
ンボーグの培地、ニッチェ−ニッチェの培地およびこれ
らの改変培地などが用いられ得る。このカルスを、さら
に液体または固体培地に移して培養することにより所望
の組織培養物が調製される。特に、オタネニンジンの組
織培養物が好ましく使用される。
The medicinal carrots used in the present invention include Panax ginseng C.A. Meyer, Panax japonicus CAMeyer, Panax quinquefolium L., Panax notoginseng (Burk.) FHChen, Himalayan carrot ( Panax pseudo-ginseng Wall. Subsp. Himalaicu
sHara), ginseng ( Panax japonics CAMeyer var. maj)
or (Burk.) CYWu et KMFeng), Panax zi
ngiberenesis CYWu et KMFeng), Heihen thirty-seven (Panax
stipuleanatus Tsai et Feng), Semaha Takefushi ginseng (Panax j
aponics CAMeyer var.angustifolitus (Burk.) Chen
g et Chu). The root of these medicated carrots or a dried product thereof is used. Such a dried product can be obtained, for example, as a Chinese medicine such as white ginseng or red ginseng. Alternatively, a medicinal carrot tissue culture can be used. Tissue cultures can be prepared by conventional methods. For example, a part of the medicinal carrot tissue is aseptically cultured in a solid medium containing a plant hormone to generate callus. Culture conditions need not be exceptional. As the medium, Murashige which is usually used for tissue culture of plants is used.
Skoog's medium, White medium, Rinsmeyer-Skoog's medium, Gausslet's medium, Heller's medium, Gamborg's medium, Nitsche-Nitsche's medium and modified media thereof can be used. The callus is further transferred to a liquid or solid medium and cultured to prepare a desired tissue culture. In particular, a tissue culture of Panax ginseng is preferably used.

【0006】本発明の方法によれば、以下のようにして
酸分泌抑制物質が単離される。まず、上記の薬用ニンジ
ンまたはその組織培養物を必要に応じて乾燥する。これ
を水性有機溶媒で抽出する。水性有機溶媒としては、メ
タノール、エタノール、アセトンなどの水と混和し得る
有機溶媒の少なくとも1種を40〜80%含有する水溶液が
用いられる。あるいは水を単独で用いてもよい。抽出時
には、薬用ニンジンを粉砕したり、抽出混合物を加温す
ることが好ましい。このような操作により、抽出が促進
される。ただし、抽出時の温度は、80℃を越えないこと
が好ましい。
According to the method of the present invention, an acid secretion inhibitor is isolated as follows. First, the above-mentioned medicinal carrot or its tissue culture is dried if necessary. This is extracted with an aqueous organic solvent. As the aqueous organic solvent, an aqueous solution containing 40 to 80% of at least one water-miscible organic solvent such as methanol, ethanol, and acetone is used. Alternatively, water may be used alone. At the time of extraction, it is preferable to pulverize the medicinal carrot or to heat the extraction mixture. Such an operation facilitates the extraction. However, the temperature at the time of extraction preferably does not exceed 80 ° C.

【0007】次いで、上記の抽出液を濾過し、濾液を減
圧濃縮する。そして、この濃縮液を水中に懸濁した後、
有機溶媒を添加して沈澱させ、沈澱物を回収する。この
沈澱処理に用いられる有機溶媒としては、メタノール、
エタノール、アセトンなどの水と混和し得る溶媒が好ま
しく用いられる。
Next, the above extract is filtered, and the filtrate is concentrated under reduced pressure. And after suspending this concentrate in water,
An organic solvent is added for precipitation, and the precipitate is collected. As an organic solvent used for this precipitation treatment, methanol,
A water-miscible solvent such as ethanol or acetone is preferably used.

【0008】上記で得られた沈澱物を再び水中に懸濁
し、これを限外濾過膜を用いて分画し、低分子画分(分
子量14000以下)を回収する。この画分を減圧濃縮し薄
層クロマトグラフィーに付すと、サポニンとは異なる位
置にスポットが認められる。
[0008] The precipitate obtained above is suspended again in water and fractionated using an ultrafiltration membrane to recover a low-molecular fraction (molecular weight of 14,000 or less). When this fraction was concentrated under reduced pressure and subjected to thin layer chromatography, spots were observed at positions different from those of saponin.

【0009】このようにして得られた、非サポニン性の
物質を、適当な助剤(例えば、甘草、白朮、および乾姜
の熱水抽出液など)と配合したところ、極めて強い中枢
性の酸分泌抑制作用が得られた。すなわち、ここで得ら
れた非サポニン性の物質は、新規な酸分泌抑制物質であ
り、適切な助剤と配合することによって、優れた酸分泌
抑制剤が得られる。さらに、この酸分泌抑制物質は、薬
用ニンジンを原料をするので人体に無害であり、これを
用いた酸分泌抑制剤は、抗潰瘍作用を有する内服薬とし
て投与することができる。
When the thus obtained non-saponinous substance is mixed with a suitable auxiliary agent (for example, a hot water extract of licorice, white jujube and dried ginger, etc.), a very strong central acid is obtained. Secretion inhibitory effect was obtained. That is, the non-saponin substance obtained here is a novel acid secretion inhibitor, and an excellent acid secretion inhibitor can be obtained by blending it with an appropriate auxiliary. Furthermore, the acid secretion inhibitor is harmless to the human body because it uses medicinal carrot as a raw material, and the acid secretion inhibitor using the same can be administered as an oral medicine having an antiulcer effect.

【0010】[0010]

【実施例】本発明を以下の実施例を用いて説明する。The present invention will be described with reference to the following examples.

【0011】A.酸分泌抑制物質の単離 オタネニンジン(Panax ginseng C.A.Meyer)の組織の
1部を、植物ホルモンを含有する寒天培地で無菌的に培
養してカルスを発生させ、このカルスを、液体培地で28
日間培養した。得られたカルスを乾燥し、40kgの乾燥カ
ルスを得た。この乾燥カルスを、50%エタノール水溶液
72リットルに入れ、70℃で1時間加熱した後、抽出液を
濾過した。残渣にさらに72リットルの50%エタノール水
溶液を加え,同様にして、加熱、抽出、および濾過を行
った。得られた濾液を先の濾液と合わせて減圧濃縮し、
7,480gの抽出物を得た。この抽出物940gを5倍量の
水に懸濁させ、この懸濁液に、懸濁液の5倍量のエタノ
ールを加えて、一晩放置した。析出した沈澱物を濾過
し、溶媒を留去して回収し、550gの沈澱物を得た。こ
の沈澱物を採取し、3リットルの水に懸濁させ、この懸
濁液を、分画分子量が12,000から14,000の透析用セルロ
ースチューブに充填し、45リットルの水に対して1日透
析を行った。水を取り替えて同じ操作を3回行った。得
られた透析外液を合わせ、減圧濃縮して523gの濃縮物
を得た。この濃縮物を薄層クロマトグラフィーに付す
と、サポニンと異なる位置に単一のスポットが確認され
た。
A. Isolation of acid secretion inhibitor A part of the tissue of Panax ginseng CAMeyer was aseptically cultured on an agar medium containing plant hormones to generate calli.
Cultured for days. The obtained callus was dried to obtain a dry callus of 40 kg. This dried callus is added to a 50% ethanol aqueous solution
After placing in 72 liters and heating at 70 ° C. for 1 hour, the extract was filtered. To the residue was further added 72 liters of a 50% aqueous ethanol solution, followed by heating, extraction and filtration in the same manner. The obtained filtrate was combined with the previous filtrate and concentrated under reduced pressure.
7,480 g of extract was obtained. 940 g of this extract was suspended in 5 times the volume of water, and the suspension was added with 5 times the volume of ethanol and left overnight. The precipitated precipitate was collected by filtration and the solvent was distilled off to obtain 550 g of a precipitate. The precipitate was collected, suspended in 3 liters of water, and the suspension was filled in a cellulose dialysis tube having a molecular weight cutoff of 12,000 to 14,000, and dialyzed against 45 liters of water for 1 day. Was. The same operation was performed three times while replacing the water. The obtained outer dialysates were combined and concentrated under reduced pressure to obtain 523 g of a concentrate. When the concentrate was subjected to thin-layer chromatography, a single spot was found at a position different from that of saponin.

【0012】B.酸分泌抑制作用の検定 Wistar系雄性ラット(体重:200〜300g)を用い、胃内
灌流法を用いて酸分泌抑制効果を検定した。
B. Assay of acid secretion inhibitory effect The Wistar strain male rat (body weight: 200 to 300 g) was used to assay the acid secretion inhibitory effect by the intragastric perfusion method.

【0013】上記A項で得られた透析外液934gを、甘
草、白朮および乾姜の熱水抽出液1000gに添加し混合し
て検液(A)とした。比較のために、生理食塩水(対
照)(B);甘草、白朮および乾姜の熱水抽出液
(C);および公知の酸分泌抑制剤である硫酸アトロピ
ンを含む溶液(D)を用いて、同様に以下の試験を行っ
た。
[0013] 934 g of the dialysis external solution obtained in the above section A was added to 1000 g of a hot water extract of licorice, white jujube and dried ginger and mixed to obtain a test solution (A). For comparison, a physiological saline solution (control) (B); a hot water extract of licorice, white jujutsu and ginger (C); and a solution (D) containing atropine sulfate, a known acid secretion inhibitor, were used. Similarly, the following tests were performed.

【0014】ラットの胃に対して、37℃に保温した生理
食塩水を1ml/分の速度で灌流し、上記の検液または比
較物質溶液を十二指腸内に投与し、1時間後に、2-デオ
キシグルコース200mg/kgを皮下投与した。2-デオキシグ
ルコースの投与から2時間の間灌流液を採取し、0.01N
NaOHでpH7.0〜7.4となるまで滴定し、酸の分泌量を測定
した。結果を表1に示す。
The rat stomach was perfused with physiological saline kept at 37 ° C. at a rate of 1 ml / min, and the test solution or the comparative substance solution was administered into the duodenum. 200 mg / kg of glucose was administered subcutaneously. Collect the perfusate for 2 hours from the administration of 2-deoxyglucose and
Titration was performed with NaOH until the pH became 7.0 to 7.4, and the amount of secreted acid was measured. Table 1 shows the results.

【0015】[0015]

【表1】 [Table 1]

【0016】表1から明らかなように、本発明の方法に
よって得られた物質は、硫酸アトロピンに匹敵する酸分
泌抑制作用を有する。
As is clear from Table 1, the substance obtained by the method of the present invention has an acid secretion inhibitory action comparable to that of atropine sulfate.

【0017】[0017]

【発明の効果】本発明の方法によれば、薬用ニンジンま
たはその組織培養物から酸分泌抑制作用を有する物質を
容易に単離することができる。本発明によって得られる
この酸分泌抑制物質は、例えば、潰瘍の予防薬または治
療薬に広く利用され得る。
According to the method of the present invention, a substance having an inhibitory action on acid secretion can be easily isolated from medicinal carrot or its tissue culture. The acid secretion inhibitor obtained by the present invention can be widely used, for example, as a preventive or therapeutic drug for ulcer.

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】薬用ニンジンまたはその組織培養物、また
はそれらの乾燥物を水性有機溶媒で抽出する工程; 得られた抽出物を有機溶媒で沈澱させ、沈澱物を採取す
る工程;および、 該沈澱物を限外濾過処理に供し、分子量14000以下の
分子画分を採取する工程;を包含する、 酸分泌抑制物質の単離方法。
1. a step of extracting a medicinal carrot or a tissue culture thereof or a dried product thereof with an aqueous organic solvent; a step of precipitating the obtained extract with an organic solvent and collecting a precipitate; Subjecting the substance to an ultrafiltration treatment to collect a low-molecular fraction having a molecular weight of 14,000 or less .
【請求項2】前記薬用ニンジンが、オタネニンジン(Pa
nax ginseng C.A.Meyer)、トチバニンジン(Panax jap
onicus C.A.Meyer)、アメリカニンジン(Panax quinqu
efolium L.)、三七ニンジン(Panax notoginseng (Bur
k.)F.H.Chen)、ヒマラヤニンジン(Panax pseudo-gins
eng Wall. subsp. himalaicus Hara)、珠子参(Panax
japonics C.A.Meyer var. major (Burk.) C.Y.Wu et K.
M.Feng)、姜状三七(Panax zingiberenesis C.Y.Wu et
K.M.Feng)、屏辺三七(Panax stipuleanatus Tsai et
Feng)、および狭葉竹節参(Panax japonics C.A.Meye
r var. angustifolitus (Burk.) Cheng et Chu)でなる
群から選択される、請求項1に記載の方法。
2. The medicinal carrot is a panax ginseng ( Pa)
nax ginseng CAMeyer), Panax jap
onicus CAMeyer), American carrot ( Panax quinqu)
efolium L.), Panax notoginseng (Bur
k.) FHChen), Himalayan carrot ( Panax pseudo-gins)
eng Wall. subsp. himalaicus Hara) , Tamako ginseng (Panax
japonics CAMeyer var.major (Burk.) CYWu et K.
M. Feng), Panax zingiberenesis CYWu et
KMFeng), Panax stipuleanatus Tsai et
Feng) and Bamboo Ginseng Saban ( Panax japonics CAMeye)
The method according to claim 1, wherein the method is selected from the group consisting of r var. angustifolitus (Burk.) Cheng et Chu).
【請求項3】請求項1に記載の方法で単離される、酸分
泌抑制物質。
3. An acid secretion inhibitor isolated by the method according to claim 1.
JP03034225A 1991-02-28 1991-02-28 Method for isolating acid secretion inhibitor Expired - Lifetime JP3121850B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03034225A JP3121850B2 (en) 1991-02-28 1991-02-28 Method for isolating acid secretion inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03034225A JP3121850B2 (en) 1991-02-28 1991-02-28 Method for isolating acid secretion inhibitor

Publications (2)

Publication Number Publication Date
JPH04273824A JPH04273824A (en) 1992-09-30
JP3121850B2 true JP3121850B2 (en) 2001-01-09

Family

ID=12408207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03034225A Expired - Lifetime JP3121850B2 (en) 1991-02-28 1991-02-28 Method for isolating acid secretion inhibitor

Country Status (1)

Country Link
JP (1) JP3121850B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6460981B1 (en) 1995-09-05 2002-10-08 Seiko Epson Corp Ink jet recording head having spacer with etched pressurizing chambers and ink supply ports
US6729002B1 (en) 1995-09-05 2004-05-04 Seiko Epson Corporation Method of producing an ink jet recording head

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI222357B (en) 2000-01-11 2004-10-21 Medical & Pharm Ind Tech & Dev Anti-ulcer pharmaceutical composition and the preparation and use thereof
CN104434676B (en) * 2014-12-04 2018-11-30 文山学院文山三七研究院 A kind of Radix Notoginseng extract powder extraction process

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6460981B1 (en) 1995-09-05 2002-10-08 Seiko Epson Corp Ink jet recording head having spacer with etched pressurizing chambers and ink supply ports
US6561633B2 (en) 1995-09-05 2003-05-13 Seiko Epson Corporation Ink jet recording head having spacer with etched pressurizing chambers and ink supply ports
US6729002B1 (en) 1995-09-05 2004-05-04 Seiko Epson Corporation Method of producing an ink jet recording head

Also Published As

Publication number Publication date
JPH04273824A (en) 1992-09-30

Similar Documents

Publication Publication Date Title
US4511559A (en) Biologically active polysaccharide concentrates and process for production of preparates containing such substances
EP0225496B1 (en) Immunostimulating polysaccharides from cell cultures of Echinacea purpurea (Linné) Moench and Echinacea angustifolia (De Vandolle), process for their preparation and pharmaceutical compositions containing them
US4755504A (en) Pharmaceutical composition from Tienchi
DK145505B (en) PROCEDURE FOR PREPARING A NITROGEN CONTAINING POLYSACCHARIDE
JPS60214741A (en) Hypoglycemic agent
JPS6289626A (en) Calcium and magnesium composite compound of phytohemagglutinin-polyheteroglycan
JP3121850B2 (en) Method for isolating acid secretion inhibitor
US4944946A (en) Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
US4629627A (en) Antiviral substance and the manufacturing method thereof
CN101340923B (en) Ethanol-precipitated phaseolus vulgaris extracts, their use and formulations
CN119912596A (en) Application of Polygonatum yunnanensis polysaccharide in preparing medicine for treating ulcerative colitis
CN105796625A (en) Pharmaceutical composition containing red yeast rice and safflower and preparation thereof
CN102010456A (en) Method for extracting pseudoginsenoside RT5 and medical application
CN114470101A (en) Traditional Chinese medicine composition and preparation method thereof, and oral preparation containing the same
US4985247A (en) Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
JPH0825894B2 (en) Antiviral agent
CN107648311B (en) Composition and medicine with antiviral and antiinflammatory effects
CN107602632B (en) Extract of fructo-oligosaccharide and its extraction method
GB2364640A (en) Composition for the treatment of peptic ulcer comprising American ginseng
CN105294879B (en) A kind of ramulus mori antitumor activity polysaccharide RMPW 2 preparation method
US6800304B2 (en) Anti-ulcer pharmaceutical composition and the preparation thereof
CN112168878B (en) Radix polygalae fallax hemsl-water lotus lipid-lowering composition and preparation method thereof
US4944945A (en) Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
JP4979053B2 (en) Anticancer agent containing gentian extract, health supplement and medicinal cosmetic, and method for producing gentian extract
CN121890754A (en) Probiotic composition for improving immunity and preparation method thereof

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20001004

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111020

Year of fee payment: 11